CHW Support for Quitting Smoking During Pregnancy (SFHOPE Trial)

N/A

Recruiting

Led By Anne Berit Petersen, PhD

Research Sponsored by Loma Linda University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age > 18 years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline; during the intervention; through study completion, an average of 10 months.

Awards & highlights

No Placebo-Only Group

Summary

"This trial is creating a new program to help pregnant women in San Bernardino County quit smoking."

Who is the study for?

This trial is for pregnant smokers in San Bernardino County who are interested in quitting smoking. Specific eligibility criteria have not been provided, but typically participants would need to be of legal age for consent and willing to follow the study procedures.

What is being tested?

The trial is testing a new behavioral tobacco cessation program designed specifically for pregnant women. Participants will either receive this specialized support from community health workers integrated into their prenatal care or be placed in a control group without this additional intervention.

What are the potential side effects?

Since the intervention involves behavioral support rather than medication, there may not be direct side effects like with drugs; however, stress or anxiety related to quitting smoking could potentially occur.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am older than 18 years.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline; during the intervention; through study completion, an average of 10 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline; during the intervention; through study completion, an average of 10 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; during the intervention; through study completion, an average of 10 months. for reporting.